This inventor holds 2 USPTO granted patents. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1976-1977.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1976-1977
Title: The Innovations of Yoshio Imashiro
Introduction
Yoshio Imashiro is a notable inventor based in Nishinomiya, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antimicrobial compounds. With a total of 2 patents, his work has had a considerable impact on therapeutic agents for bacterial infections.
Latest Patents
Imashiro's latest patents include the development of 7-Acetoacetamidocephem compounds. These novel compounds possess a broad antimicrobial spectrum and are readily absorbed into the living body, making them useful as therapeutic agents for various bacterial infections in both animals and humans. Another significant patent involves a process for producing lactol-type cephalosporins. This process allows for the direct oxidation of a 3-hydroxymethylcephalosporin, resulting in valuable intermediates for preparing 3-alkoxyiminomethyl cephalosporins.
Career Highlights
Yoshio Imashiro is associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company. His work at Takeda has been instrumental in advancing the development of new antimicrobial agents. His innovative approaches and research have contributed to the company's reputation for excellence in pharmaceutical development.
Collaborations
Imashiro has collaborated with notable coworkers such as Mitsuo Numata and Masayoshi Yamaoka. These collaborations have fostered a productive environment for innovation and research within the pharmaceutical field.
Conclusion
Yoshio Imashiro's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of effective therapeutic agents for bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
